D
7607
vs
T
Taiwan Weighted Index
In den letzten 12 Monate hat DuoGenic StemCells Corp schlechter abgeschnitten als Taiwan Weighted Index, und erzielte eine Rendite von -41% gegenüber Taiwan Weighted Index +92% Anstieg.
Aktienperformance
7607 vs Taiwan Weighted Index
Performance-Unterschied
7607 vs Taiwan Weighted Index
Performance nach Jahr
7607 vs Taiwan Weighted Index
Vergleichen Sie die Rendite der Aktie mit ihrem Benchmark-Index und Wettbewerbern. Erhalten Sie Einblicke in die relative Performance im Zeitverlauf.
Performance der Wettbewerber
DuoGenic StemCells Corp vs Wettbewerber
DuoGenic StemCells Corp
Kurzüberblick
Duogenic Stemcells Corp. engages in the provision of biotechnology and medical care services. The company is headquartered in Taichung, Taichung and currently employs 25 full-time employees. The company went IPO on 2023-05-25. The culture medium provides the nutrients and raw materials needed for cell growth and reproduction. The cell separator set is used to draw peripheral blood to purify and isolate mononuclear cells. Products include mesenchymal stem cell culture media, endothelial cell culture media, closed cell separation operating devices and others. Products are mainly sold in Taiwan, Asia, and North America.
